Item 1.01 Entry into a Material Definitive Agreement.
On February 3, 2021, as contemplated by the terms of the amended and restated
loan and security agreement, dated June 28, 2019, by and between Puma
Biotechnology, Inc. (the "Company") and Oxford Finance LLC ("Oxford"), as
collateral agent and lender, as amended February 27, 2020, July 6, 2020 and
August 5, 2020 (the "Credit Facility"), the Company and Oxford amended the
Credit Facility to amend the Company's minimum revenue thresholds for the
trailing year to date periods ending March 31, June 30, September 30 and
December 31, 2021 (the "Fourth Amendment"). Other than as set forth in the
Fourth Amendment, the terms of the Credit Facility remain in full force and
effect.
The foregoing description of the Fourth Amendment is qualified in its entirety
by reference to the Fourth Amendment, a copy of which will be filed as an
exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended
March 31, 2021.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses